• Home
  • Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Author List
Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF
Publication
Journal of neuro-oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/234691033
Publication Year
2014
PubMed ID
24803001
Publication Title
Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF. Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.